Neil Abdollahian
2016
In 2016, Neil Abdollahian earned a total compensation of $945.6K as Chief Business Officer at Cidara Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $57,186 |
|---|---|
| Option Awards | $725,890 |
| Salary | $162,500 |
| Total | $945,576 |
Abdollahian received $725.9K in option awards, accounting for 77% of the total pay in 2016.
Abdollahian also received $57.2K in non-equity incentive plan and $162.5K in salary.
Rankings
In 2016, Neil Abdollahian's compensation ranked 8,515th out of 14,075 executives tracked by ExecPay. In other words, Abdollahian earned more than 39.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,515 out of 14,075 | 40th |
Division Manufacturing | 3,271 out of 5,489 | 40th |
Major group Chemicals And Allied Products | 1,103 out of 1,895 | 42nd |
Industry group Drugs | 861 out of 1,538 | 44th |
Industry Biological Products, Except Diagnostic Substances | 151 out of 279 | 46th |
Source: SEC filing on April 28, 2017.
Abdollahian's colleagues
We found three more compensation records of executives who worked with Neil Abdollahian at Cidara Therapeutics in 2016.